Predictive value of remission status after 6 months induction therapy in patients with proliferative lupus nephritis: A retrospective analysis

Clinical Rheumatology

Volumn 30, Issue 11, 2011, Pages 1399-1405

  So, Min Wook ^a   Koo, Bon San ^a   Kim, Yong Gil ^a   Lee, Chang Keun ^a   Yoo, Bin ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

Induction; Lupus nephritis; Remission; Systemic lupus erythematosus

Indexed keywords

ANTINUCLEAR ANTIBODY; AZATHIOPRINE; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; CORTICOSTEROID; CREATININE; CYCLOPHOSPHAMIDE; DOUBLE STRANDED DNA ANTIBODY; HEMOGLOBIN; PREDNISOLONE;

ADULT; ALBUMIN BLOOD LEVEL; ANTIBODY TITER; ARTICLE; CHRONIC KIDNEY FAILURE; CREATININE BLOOD LEVEL; ERYTHROCYTE COUNT; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; KIDNEY BIOPSY; LATENT PERIOD; LEUKOCYTE COUNT; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN URINE LEVEL; PROTEINURIA; RELAPSE; REMISSION; RETROSPECTIVE STUDY; THROMBOCYTE COUNT; TREATMENT OUTCOME; URINE SEDIMENT;

ADOLESCENT; ADULT; FEMALE; FOLLOW-UP STUDIES; HUMANS; KIDNEY; KIDNEY FAILURE, CHRONIC; LUPUS NEPHRITIS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REMISSION INDUCTION; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 80755138375     PISSN: 07703198     EISSN: 14349949     Source Type: Journal    
DOI: 10.1007/s10067-011-1778-2     Document Type: Article

References (29)

1. JS Cameron 1999 Lupus nephritis J Am Soc Nephrol 10 413 424 10215343 1:STN:280:DyaK1M7ktVajsQ%3D%3D (Pubitemid 29068083)
2. L Martins G Rocha A Rodrigues J Santos C Vasconcelos J Correia F Farinha I Almeida P Barbosa S Guimaraes 2002 Lupus nephritis: a retrospective review of 78 cases from a single center Clin Nephrol 57 114 119 11863120 1:STN:280:DC%2BD387isl2gug%3D%3D (Pubitemid 34145194)
3. JR MacGowan S Ellis M Griffiths DA Isenberg 2002 Retrospective analysis of outcome in a cohort of patients with lupus nephritis treated between 1977 and 1999 Rheumatology (Oxford) 41 981 987 10.1093/rheumatology/41.9.981 1:CAS:528:DC%2BD38XmvVCqt74%3D
4. GB Appel DJ Cohen CL Pirani JI Meltzer D Estes 1987 Long-term follow-up of patients with lupus nephritis. A study based on the classification of the World Health Organization Am J Med 83 877 885 3674094 10.1016/0002-9343(87) 90645-0 1:STN:280:DyaL1c%2Fks1yquw%3D%3D (Pubitemid 18098162)
5. HA Austin 3rd DT Boumpas EM Vaughan JE Balow 1994 Predicting renal outcomes in severe lupus nephritis: contributions of clinical and histologic data Kidney Int 45 544 550 8164443 10.1038/ki.1994.70 (Pubitemid 24065091)
6. G Contreras V Pardo C Cely E Borja A Hurtado C De La Cuesta K Iqbal O Lenz A Asif N Nahar B Leclerq C Leon I Schulman F Ramirez-Seijas A Paredes A Cepero T Khan F Pachon E Tozman G Barreto D Hoffman M Almeida Suarez JC Busse M Esquenazi A Esquenazi L Garcia Mayol H Garcia Estrada 2005 Factors associated with poor outcomes in patients with lupus nephritis Lupus 14 890 895 16335581 10.1191/0961203305lu2238oa 1:CAS:528:DC%2BD28XnvFA%3D (Pubitemid 41736370)
7. CA Arce-Salinas AR Villa JO Martinez-Rueda L Munoz MH Cardiel J Alcocer-Varela D Alarcon-Segovia 1995 Factors associated with chronic renal failure in 121 patients with diffuse proliferative lupus nephritis: a case-control study Lupus 4 197 203 7655489 10.1177/096120339500400306 1:STN:280:DyaK2MzosVWrsg%3D%3D
8. RH Derksen RJ Hene L Kater 1992 The long-term clinical outcome of 56 patients with biopsy-proven lupus nephritis followed at a single center Lupus 1 97 103 1301970 10.1177/096120339200100207 1:STN:280:DyaK3s3ltV2hsA%3D%3D
9. RC Ravinal RS Costa TM Coimbra MT Pastorello EB Coelho M Dantas RM dos 2002 Classes, activity and chronicity indices, and alpha-smooth muscle actin expression as prognostic parameters in lupus nephritis outcome Lupus 11 82 87 11958582 10.1191/0961203302lu153oa (Pubitemid 34259437)
10. HC Nossent SC Henzen-Logmans TM Vroom JH Berden TJ Swaak 1990 Contribution of renal biopsy data in predicting outcome in lupus nephritis. Analysis of 116 patients Arthritis Rheum 33 970 977 2369432 10.1002/art. 1780330708 1:STN:280:DyaK3czhsFSjsg%3D%3D (Pubitemid 20226350)
11. TM Chan KC Tse CS Tang KN Lai FK Li 2005 Long-term outcome of patients with diffuse proliferative lupus nephritis treated with prednisolone and oral cyclophosphamide followed by azathioprine Lupus 14 265 272 15864912 10.1191/0961203305lu2081oa 1:CAS:528:DC%2BD2MXktlOrsLo%3D (Pubitemid 40559171)
12. SM Korbet EJ Lewis MM Schwartz M Reichlin J Evans RD Rohde 2000 Factors predictive of outcome in severe lupus nephritis. Lupus Nephritis Collaborative Study Group Am J Kidney Dis 35 904 914 10793026 10.1016/S0272-6386(00)70262-9 1:STN:280:DC%2BD3c3lsFWhsg%3D%3D (Pubitemid 30238204)
13. YE Chen SM Korbet RS Katz MM Schwartz EJ Lewis 2008 Value of a complete or partial remission in severe lupus nephritis Clin J Am Soc Nephrol 3 46 53 18003764 10.2215/CJN.03280807 1:CAS:528:DC%2BD1cXhs1eitLw%3D
14. J Golbus WJ McCune 1994 Lupus nephritis. Classification, prognosis, immunopathogenesis, and treatment Rheum Dis Clin North Am 20 213 242 8153400 1:STN:280:DyaK2c3gsVejsw%3D%3D (Pubitemid 24066018)
15. HA Austin 3rd JH Klippel JE Balow NG le Riche AD Steinberg PH Plotz JL Decker 1986 Therapy of lupus nephritis. Controlled trial of prednisone and cytotoxic drugs N Engl J Med 314 614 619 3511372 10.1056/NEJM198603063141004 (Pubitemid 16132725)
16. DT Boumpas HA Austin 3rd EM Vaughn JH Klippel AD Steinberg CH Yarboro JE Balow 1992 Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis Lancet 340 741 745 1356175 10.1016/0140-6736(92)92292-N 1:STN:280:DyaK38vgvVentQ%3D%3D
17. MF Gourley HA Austin 3rd D Scott CH Yarboro EM Vaughan J Muir DT Boumpas JH Klippel JE Balow AD Steinberg 1996 Methylprednisolone and cyclophosphamide, alone or in combination, in patients with lupus nephritis. A randomized, controlled trial Ann Intern Med 125 549 557 8815753 1:CAS:528:DyaK28XmsFClsLs%3D (Pubitemid 126450087)
18. G Contreras V Pardo B Leclercq O Lenz E Tozman P O'Nan D Roth 2004 Sequential therapies for proliferative lupus nephritis N Engl J Med 350 971 980 14999109 10.1056/NEJMoa031855 1:CAS:528:DC%2BD2cXhvFGjsrc%3D (Pubitemid 38269274)
19. HA Austin 3rd LR Muenz KM Joyce TA Antonovych ME Kullick JH Klippel JL Decker JE Balow 1983 Prognostic factors in lupus nephritis. Contribution of renal histologic data Am J Med 75 382 391 6351607 10.1016/0002-9343(83)90338-8 (Pubitemid 13005770)
20. YG Kim HW Kim YM Cho JS Oh SS Nah CK Lee B Yoo 2008 The difference between lupus nephritis class IV-G and IV-S in Koreans: focus on the response to cyclophosphamide induction treatment Rheumatology (Oxford) 47 311 314 10.1093/rheumatology/kem365 1:CAS:528:DC%2BD1cXitlKktLY%3D (Pubitemid 351267197)
21. CC Mok RW Wong CS Lau 1999 Lupus nephritis in Southern Chinese patients: clinicopathologic findings and long-term outcome Am J Kidney Dis 34 315 323 10430980 10.1016/S0272-6386(99)70361-6 1:CAS:528:DyaK1MXltlOmsrs%3D (Pubitemid 29362098)
22. FA Houssiau C Vasconcelos D D'Cruz GD Sebastiani GE de Ramon MG Danieli D Abramovicz D Blockmans A Mathieu H Direskeneli M Galeazzi A Gul Y Levy P Petera R Popovic R Petrovic RA Sinico R Cattaneo J Font G Depresseux JP Cosyns R Cervera 2004 Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis: lessons from long-term followup of patients in the Euro-Lupus Nephritis Trial Arthritis Rheum 50 3934 3940 15593207 10.1002/art.20666 (Pubitemid 39643941)
23. JM Esdaile C Levinton W Federgreen JP Hayslett M Kashgarian 1989 The clinical and renal biopsy predictors of long-term outcome in lupus nephritis: a study of 87 patients and review of the literature Q J Med 72 779 833 2694209 1:STN:280:DyaK3c7jvFCgug%3D%3D (Pubitemid 19230673)
24. M Faurschou H Starklint P Halberg S Jacobsen 2006 Prognostic factors in lupus nephritis: diagnostic and therapeutic delay increases the risk of terminal renal failure J Rheumatol 33 1563 1569 16881113 (Pubitemid 44168828)
25. C Fiehn Y Hajjar K Mueller R Waldherr AD Ho K Andrassy 2003 Improved clinical outcome of lupus nephritis during the past decade: importance of early diagnosis and treatment Ann Rheum Dis 62 435 439 12695156 10.1136/ard.62.5.435 1:STN:280:DC%2BD3s7pvVagtg%3D%3D (Pubitemid 36469735)
26. CC Mok CT Ho KW Chan CS Lau RW Wong 2002 Outcome and prognostic indicators of diffuse proliferative lupus glomerulonephritis treated with sequential oral cyclophosphamide and azathioprine Arthritis Rheum 46 1003 1013 11953978 10.1002/art.10138 1:CAS:528:DC%2BD38Xjs12ltL4%3D (Pubitemid 34303813)
27. CC Mok KY Ying WL Ng KW Lee CH To CS Lau RW Wong TC Au 2006 Long-term outcome of diffuse proliferative lupus glomerulonephritis treated with cyclophosphamide Am J Med 119 355 e325 e333
28. JP Ioannidis KA Boki ME Katsorida AA Drosos FN Skopouli JN Boletis HM Moutsopoulos 2000 Remission, relapse, and re-remission of proliferative lupus nephritis treated with cyclophosphamide Kidney Int 57 258 264 10620207 10.1046/j.1523-1755.2000.00832.x 1:CAS:528:DC%2BD3cXivFOlu7c%3D (Pubitemid 30227773)
29. MM Schwartz SP Lan J Bernstein GS Hill K Holley EJ Lewis 1992 Role of pathology indices in the management of severe lupus glomerulonephritis. Lupus Nephritis Collaborative Study Group Kidney Int 42 743 748 1405352 10.1038/ki.1992.342 1:STN:280:DyaK3s%2Fit1eksg%3D%3D